Ask if prior authorization is required, and if so, what documentation is needed
While both Ozempic and Wegovy contain semaglutide, their FDA approval and intended uses are different
You would not be suing your doctor or pharmacist for prescribing Wegovy or fulfilling a prescription
In a new, not-yet-peer-reviewed paper, research led by scientist Varun Dwaraka of the TruDiagnostic aging lab in Kentucky suggests that once-weekly shots of semaglutide, the GLP-1 drug in Ozempic and its weight loss sister drug Wegovy, can reduce ones biological age by up to three years
These results are unprecedented for any pharmaceutical intervention targeting metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD)
Semaglutide acts like GLP-1, which assists in boosting insulin release, stopping glucagon secretion and delaying stomach emptying